Department News | April 30, 2026
We are proud to announce that on April 28, UW Medicine officially dedicated the newly named Frank Chopp Center for Behavioral Health and Learning. The new name was approved by the UW Board of Regents to honor the visionary leadership and legacy of former state Rep. Frank Chopp.
UW Medicine Newsroom | April 29, 2026
“Chopp’s longstanding support for mental health treatment has helped many more patients and their families get the help they need,” said Jürgen Unützer, MD, MPH.
Department News | March 30, 2026
The Garvey Institute for Brain Health Solutions 2025 Annual Report is now available, and we’re excited to share it with you.
Department News | March 30, 2026
The Garvey Institute Center for Neuromodulation reached an important milestone in March when, for the first time, they cared for 100 patients with state-of-the-art neuromodulation treatments such as ECT and TMS in a single week.
Department News | February 25, 2026
We are excited to announce that Mark Duncan, MD will lead the department’s Division of Addiction Psychiatry as the inaugural holder of the Nicole K. Engel Endowed Professorship for Addiction Psychiatry.
Department News | February 25, 2026
We are excited to announce that Mark Duncan, MD will lead the department’s Division of Addiction Psychiatry as the inaugural holder of the Nicole K. Engel Endowed Professorship for Addiction Psychiatry.
Department News | January 28, 2026
Supporting a loved one with a serious mental illness can be hard, particularly if they need to be hospitalized, so we produced this short video, narrated by FACTS Director Mollie Forrester, MSW, LICSW, to help families and caregivers navigate this journey and let them know what to expect when their loved one is receiving care at the CBHL.
UW Medicine Newsroom | January 21, 2026
A study led by Rebecca Hendrickson, MD, PhD found persistent COVID-19 symptoms after infection are more likely in people who have experienced traumatic stress.
UW Daily | January 5, 2026
Nathan Sackett, PhD leads a clinical trial using psilocybin to treat PTSD and alcohol abuse disorder among veterans and first responders.